AlphaMoats
Health Care

GAIN THERAPEUTICS INC GANX

$2.03
Price at quarter end (Q3 2026)
Superinvestor owners
1
Rank #1550 by number of owners
% of all portfolios
0.00%
Rank #1541 by combined value
Net managers Q2 2026
0
No one entered or exited
Hold price
—
Weighted avg. reported price
Largest position
0.0%
of David Einhorn's portfolio

Live price

Compare with the quarter-end price of $2.03 reported in the 13F

Superinvestors holding GANX

Recent activity
David Einhorn · Greenlight Capital (DME Capital Management)
0.0%
—$1.1M